Anthera Pharmaceuticals, Inc. (ANTH) Reports 2013 First Quarter Financial Results
5/14/2013 6:57:16 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Announces Additional Data From Phase 2b PEARL-SC Blisibimod Study
5/8/2013 10:05:40 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Announces First Quarter 2013 Financial Report and Conference Call
5/6/2013 6:20:24 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Secures $20 Million Debt Financing Facility
4/8/2013 6:59:31 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
3/28/2013 8:43:38 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2012 Fourth Quarter and Fiscal Year Financial Results
3/27/2013 7:10:46 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Announces Data From the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
3/22/2013 9:35:26 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) to Present at the 2013 Leerink Swann and Company Global Healthcare Conference
2/8/2013 7:18:55 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Announces Departure of Georgina Kilfoil
2/5/2013 10:04:23 AM
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion of Public Offering of Common Stock
1/30/2013 9:52:54 AM
More...
|
|